Is the use of neuromuscular blocking agents contraindicated in ''poor risk'' patients?
D004194:Disease; D006801:Humans; D009125:Muscle Relaxants, Central / Q000633:toxicity*; D009466:Neuromuscular Blocking Agents; D012137:Respiratory System; D012140:Respiratory Tract Diseases; D012306:Risk; D013514:Surgical Procedures, Operative / Q000150:complications*
D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents
MUSCLE RELAXANTS/toxicology; RESPIRATORY SYSTEM/diseases; SURGERY, OPERATIVE/complications